Overview
My research has focused on cancer cell metabolism and the molecular pathways that regulate posttranslational modifications. In addition, we explore cancer initiation, cell survival, progression, and metastasis using a variety of in vitro, ex vivo, and in vivo genetical approaches, including gene knockdown, CRISPR/Cas9 knockout, molecular biology techniques, biochemical approaches, and genetically engineered mouse and Nude mice models, to characterize molecular mechanisms regulated by metabolic pathways and develop potential metabolic strategies for cancer therapy.
Current Duke Appointments & Affiliations
Postdoctoral Associate
Pathology,
Clinical Science Departments
Recent Scholarly Works
Mitochondrial Dynamics in Cancer Progression and Therapy Resistance: Emerging Roles in Metabolic Reprogramming, Biomarker Discovery, and Precision Medicine.
Journal article Cells · June 2, 2026 Mitochondria play essential roles in cellular metabolism and signaling, regulating biosynthetic pathways, calcium homeostasis, redox balance, and cell fate beyond ATP production. Their continual remodeling through fusion, fission, and mitophagy maintains m ... Full text Link to item CiteCore Values: Does Clusterin Functionally Link HCV Core Protein Signaling to Malignant Phenotypes in HCV-Associated HCC?
Journal article Digestive diseases and sciences · March 2026 Full text CiteALDH4A1 functions as an active component of the MPC complex maintaining mitochondrial pyruvate import for TCA cycle entry and tumour suppression.
Journal article Nat Cell Biol · May 2025 MPC1 and MPC2 are two well-known components of the mitochondrial pyruvate carrier (MPC) complex maintaining MPC activity to transport pyruvate into mitochondria for tricarboxylic acid (TCA) cycle entry in mammalian cells. It is currently unknown whether th ... Full text Open Access Link to item CiteRecent Grants
Unravel a novel metabolic pathway orchestrating prostate cancer progression and therapeutic resistance
ResearchPostdoctoral Associate · Awarded by National Cancer Institute · 2023 - 2027Regulation of oncogenic Akt ubiquitination and activation by diverse mechanisms in cancer
ResearchPostdoctoral Associate · Awarded by National Cancer Institute · 2023 - 2026View All Grants